Institutional Ownership Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the 1,462 institutions that hold shares in the stock, with a total of 84.9 Million shares, which have been reported (via 13F filing form) to have a value of $46.7 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
9,407,891
shares
|
$5.17 Billion
0.11% of portfolio
|
Q1 2025
Added 1.31%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,446,366
shares
|
$4.65 Billion
0.2% of portfolio
|
Q2 2024
Reduced 1.43%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
5,658,197
shares
|
$3.11 Billion
0.28% of portfolio
|
Q1 2025
Reduced 19.85%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
4,789,659
shares
|
$2.63 Billion
0.13% of portfolio
|
Q1 2025
Reduced 0.88%
|
|
Capital International Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
3,989,132
shares
|
$2.19 Billion
0.52% of portfolio
|
Q1 2025
Reduced 15.79%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,469,585
shares
|
$1.36 Billion
0.13% of portfolio
|
Q1 2025
Added 1.73%
|
|
Dodge & Cox
San Francisco, CA |
May 14, 2025 Q1 2025 |
2,324,085
shares
|
$1.28 Billion
0.9% of portfolio
|
Q1 2025
Added 0.12%
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
2,276,675
shares
|
$1.25 Billion
0.44% of portfolio
|
Q1 2025
Added 11.32%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,175,026
shares
|
$1.2 Billion
0.17% of portfolio
|
Q1 2025
Added 4.3%
|
|
Capital World Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
1,938,634
shares
|
$1.07 Billion
0.21% of portfolio
|
Q1 2025
Reduced 30.24%
|
|
Loomis Sayles & CO L P
|
May 14, 2025 Q1 2025 |
1,635,981
shares
|
$900 Million
1.5% of portfolio
|
Q1 2025
Added 3.85%
|
|
Amundi
Paris, I0 |
May 15, 2025 Q1 2025 |
1,603,901
shares
|
$882 Million
0.37% of portfolio
|
Q1 2025
Added 3.36%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,250,954
shares
|
$688 Million
0.06% of portfolio
|
Q1 2025
Reduced 12.54%
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
1,210,735
shares
|
$666 Million
1.46% of portfolio
|
Q4 2023
Added 2.05%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
1,044,237
shares
|
$574 Million
0.05% of portfolio
|
Q1 2025
Added 11.07%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,001,750
shares
|
$551 Million
0.1% of portfolio
|
Q1 2025
Reduced 5.03%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
940,336
shares
|
$517 Million
0.16% of portfolio
|
Q1 2025
Reduced 4.25%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
850,746
shares
|
$468 Million
0.11% of portfolio
|
Q1 2025
Reduced 1.56%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
837,093
shares
|
$460 Million
0.09% of portfolio
|
Q1 2025
Reduced 26.77%
|
|
Legal & General Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
747,033
shares
|
$411 Million
0.13% of portfolio
|
Q4 2023
Added 10.66%
|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
722,467
shares
|
$397 Million
0.29% of portfolio
|
Q1 2025
Added 2.11%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
710,335
shares
|
$391 Million
0.09% of portfolio
|
Q1 2025
Added 2.09%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
702,892
shares
|
$387 Million
0.54% of portfolio
|
Q1 2025
Added 59.15%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
609,608
shares
|
$335 Million
0.15% of portfolio
|
Q1 2025
Reduced 2.17%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
578,889
shares
|
$318 Million
0.37% of portfolio
|
Q1 2025
Added 15.72%
|